Clinical Trial Update: Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and potential activity of venetoclax in combination with ixazomib citrate and dexamethasone in relapsed multiple myeloma h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ixazomib citrate (Ixazomib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Plasma Cell Myeloma, T(11;14) | Phase 1 | Status: COMPLETED